New EU4Health contract to develop a medical device for rapid antimicrobial susceptibility testing

On behalf of the European Commission, HaDEA has signed a contract with a consortium of European companies to develop a groundbreaking diagnostic device that will provide antimicrobial susceptibility results on bacteria within an hour. This new device will help clinicians choose the appropriate treatments for patients who might need antibiotics, therefore reducing the risks associated with AMR. Funded under the EU4Health programme, the contract was signed for a total amount of €8 850 000 and ...